Karo Pharma: Year-end report 2021

HUDDINGE, Sweden, Feb. 25, 2022 /PRNewswire/ -- Q4, October - December Revenues amounted to MSEK 762.0 (721.2), corresponding to an increase of +6% for the period. The

Related Keywords

Sweden ,Stockholm ,United Kingdom ,London ,City Of ,Huddinge ,Swedish ,Karo Pharma ,Christoffer Lorenzen ,Jon Johnsson , ,Operating Profit ,Performance Measures ,Hospital Supply ,Alpha Foods ,Northern Europe ,Nasdaq Stockholm ,Nasdaq First North ,Bokaro ,Dharma ,Ear ,Report ,021 ,